title: Pathogenesis of placental site trophoblastic tumor may require the presence of a paternally derived X chromosome.
abstract: Placental site trophoblastic tumor (PSTT) is a neoplastic proliferation of intermediate trophoblasts that invades the myometrium at the placental site after a pregnancy. Less than 100 cases have been reported. Information of the sex assignment of the antecedent gestation is available in 21 cases: 18 of these were female. To explore this interesting phenomenon, we have determined the sex chromosome composition of the tumor tissue preserved in paraffin blocks for five new cases of this condition. The last documented gestational event included a normal vaginal delivery of female infants in three cases, normal vaginal delivery of an infant of unknown sex in one case and a molar gestation in one case. Using the X-linked human androgen receptor (AR) gene as a polymorphic marker, we showed that in all five cases the tumor had a likely XX chromosomal composition; and in four cases it was possible to determine that one of the X chromosomes was of paternal origin. In one case, the paternal X chromosome showed no polymorphism to either maternal X chromosomes. In addition, sensitive semi-nested PCR failed to show a human Y chromosome element in any of the five cases of PSTT. Overall, of 21 cases from the literature and 5 cases of ours, 89% (23 of 26) showed an XX genomic composition in PSTT, either by history or genetic analysis. These results suggest that most PSTT were derived from the antecedent female conceptus and were likely to have possessed a functional paternal X chromosome. Methylation status analysis at the AR locus was performed in the three PSTT in which the paternal X chromosome was identifiable. In two cases, the paternal AR locus was hypomethylated while the corresponding maternal locus was hypermethylated. The methylation status of other loci was not investigated. Collectively, sex chromosome analysis of five cases of PSTT with literature support suggests a unique genetic basis for the development of PSTT that involves the paternal X chromosome. Although largely speculative, an active paternal X chromosome may be of importance in the pathogenesis of PSTT.
authors.affiliation: Department of Pathology, Yale University Medical School, New Haven, Connecticut, USA. pei.hui@yale.edu
authors.forename: P
authors.initials: P
authors.lastname: Hui
authors.forename: V
authors.initials: V
authors.lastname: Parkash
authors.forename: A S
authors.initials: AS
authors.lastname: Perkins
authors.forename: M L
authors.initials: ML
authors.lastname: Carcangiu
mesh_terms: D000328:Adult; D019175:DNA Methylation; D005260:Female; D018392:Genomic Imprinting; D006801:Humans; D016239:MEDLINE; D008297:Male; D008875:Middle Aged; D009215:Myometrium / Q000473:pathology; D010920:Placenta / Q000473:pathology*; D011110:Polymorphism, Genetic; D011247:Pregnancy; D011944:Receptors, Androgen / Q000235:genetics*; D018911:Trinucleotide Repeats; D014328:Trophoblastic Neoplasms / Q000235:genetics* / Q000473:pathology*; D014594:Uterine Neoplasms / Q000235:genetics* / Q000473:pathology*; D014960:X Chromosome
chemical_list: D011944:Receptors, Androgen